IL17A and Sjogren syndrome: Studies on the interaction between MSCs and Th17 cells showed that MSCs and their exosomes treatment can significantly reduce the percentage of Th17 cells and the expression of IL-17 in experimental autoimmune uveitis [59] and Sjögren’s syndrome [60] models.